Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Keytruda may prolong survival compared with standard therapy.
Keytruda and Imfinzi were well tolerated and responses were similar to those seen in HIV-negative people.
Treatment with checkpoint inhibitors appears safe and effective for HIV-positive people.
Six out of nine patients experienced cancer remission with Opdivo or Keytruda.
Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials.
Cancer and HIV are invaders that the immune system fails to detect, and the similarities don’t end there.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.